BSF Enterprise Plc

1.00pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:BSFAHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 7Y CAGR (19.85%)
Div yield —
ROE (55.01%)
Biotechnology
Beta (5Y) 3.74
PE TTM —
TSR TTM (68.25%)
Mkt cap £1.918M
ROIC (31.21%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
1.08p
8.30%
(65.82%)
Hold 12|5|4|6|6
1Q26
2Q26
3Q26
4Q26
Earnings per share£
0.02
0.02
0.02
0.02
19.38%
21.89%
29.21%
35.54%
Revenue£M
0.128
0.132
0.139
0.143
8.40%
6.60%
12.28%
12.28%
Peers (US$2.468M)
Cap (US$)
PE
3.863M
—
2.665M
—
2.387M
—
Capital
TTM
5Y
10Y
Leveragex
0.271
(0.018)
(0.017)
EBIT/Intx
1.048
0.564
0.567
Own earn%
(21.21)
(25.57)
(31.84)
Sh yield%
53.00
33.53
34.81
Owners
Insiders/Inst%
14.32
56.86
Short interest%
3.66
SBC / revenue%
0.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
10–21
$1 testx
—
Incr. ROIC%
41